We established an online registry of coronavirus disease-associated mucormycosis cases in India. We analyzed data from 65 cases diagnosed during April-June 2021, when the Delta variant predominated, and found that patients frequently received antibacterial drugs and zinc supplementation. Online registries rapidly provide relevant data for emerging infections.
Keywords: 2019 novel coronavirus disease; COVID-19; India; SARS-CoV-2; coronavirus disease; coronaviruses; corticosteroids; fungal infections; fungi; fungus; mucormycosis; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.